BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 23270866)

  • 1. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.
    Lo WK; Chan WW
    Clin Gastroenterol Hepatol; 2013 May; 11(5):483-90. PubMed ID: 23270866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    Su T; Lai S; Lee A; He X; Chen S
    J Gastroenterol; 2018 Jan; 53(1):27-36. PubMed ID: 28770351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.
    Ratuapli SK; Ellington TG; O'Neill MT; Umar SB; Harris LA; Foxx-Orenstein AE; Burdick GE; Dibaise JK; Lacy BE; Crowell MD
    Am J Gastroenterol; 2012 May; 107(5):730-5. PubMed ID: 22334250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth.
    Jacobs C; Coss Adame E; Attaluri A; Valestin J; Rao SS
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1103-11. PubMed ID: 23574267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short article: Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.
    Cares K; Al-Ansari N; Macha S; Zoubi N; Zaghloul H; Thomas R; Lalinsky P; El-Baba M
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):396-399. PubMed ID: 28030512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of continuous proton pump inhibitor therapy on small intestinal bacterial overgrowth in elderly].
    Zhang R; Li Y; Ma JX; Tang S; Li CM; Wan J
    Zhonghua Nei Ke Za Zhi; 2020 Sep; 59(9):706-710. PubMed ID: 32838502
    [No Abstract]   [Full Text] [Related]  

  • 9. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis.
    Losurdo G; Marra A; Shahini E; Girardi B; Giorgio F; Amoruso A; Pisani A; Piscitelli D; Barone M; Principi M; Di Leo A; Ierardi E
    Neurogastroenterol Motil; 2017 Jun; 29(6):. PubMed ID: 28191721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests.
    Fujiwara Y; Watanabe T; Muraki M; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Arakawa T
    Hepatogastroenterology; 2015; 62(138):268-72. PubMed ID: 25916046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Small Intestinal Bacterial Overgrowth and Symptoms After 7 Days of Proton Pump Inhibitor Use: A Study on Healthy Volunteers.
    Durán-Rosas C; Priego-Parra BA; Morel-Cerda E; Mercado-Jauregui LA; Aquino-Ruiz CA; Triana-Romero A; Amieva-Balmori M; Velasco JAV; Remes-Troche JM
    Dig Dis Sci; 2024 Jan; 69(1):209-215. PubMed ID: 37910339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Spiegel BM; Talley NJ; Moayyedi P
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1279-86. PubMed ID: 19602448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.
    Feng X; Li XQ; Jiang Z
    Clin Rheumatol; 2021 Aug; 40(8):3039-3051. PubMed ID: 33426631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI).
    Ní Chonchubhair HM; Bashir Y; Dobson M; Ryan BM; Duggan SN; Conlon KC
    Pancreatology; 2018 Jun; 18(4):379-385. PubMed ID: 29502987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?
    Spiegel BM; Chey WD; Chang L
    Am J Gastroenterol; 2008 Dec; 103(12):2972-6. PubMed ID: 19086951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care.
    DE Bastiani R; Lopetuso LR; DE Bastiani M; Bacchin P; Benedetto E; Boscariolo L; Caneve R; Chesani F; Chiumeo F; Civic Z; Dainese A; DE Polo M; Disclafani G; Grattagliano I; Mana O; Mancuso M; Mastronuzzi T; Pati A; Pirrotta E; Salandini M; Sanna G; Scoglio R; Severino P; Tosetti C; Turnava L; Zamparella M; Elisei W; Gasbarrini A; Tursi A
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):523-528. PubMed ID: 36943203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndrome of bacterial overgrowth in patients with the reduced stomach acid secretion: some aspects of the diagnosis].
    Ardatskaia MD; Loginov VA; Minushkin ON
    Eksp Klin Gastroenterol; 2014; (12):30-6. PubMed ID: 26058109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.
    Giamarellos-Bourboulis EJ; Pyleris E; Barbatzas C; Pistiki A; Pimentel M
    BMC Gastroenterol; 2016 Jul; 16(1):67. PubMed ID: 27402085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis.
    Feng X; Li XQ
    Aging (Albany NY); 2022 Jan; 14(2):975-988. PubMed ID: 35086065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.